Linx S.A. ADR (LINX)

7.5  -0.2 (-2.6%)

Fundamental Rating

2

Taking everything into account, LINX scores 2 out of 10 in our fundamental rating. LINX was compared to 276 industry peers in the Software industry. Both the profitability and financial health of LINX have multiple concerns. LINX is valued expensive and it does not seem to be growing.



Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year LINX has reported negative net income.

1.2 Ratios

Industry RankSector Rank
ROA -3.12%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -5.11%
PM (TTM) -8.93%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

3

2. Health

2.1 Basic Checks

There is no outstanding debt for LINX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

An Altman-Z score of 5.33 indicates that LINX is not in any danger for bankruptcy at the moment.
A Debt/Equity ratio of 0.13 indicates that LINX is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Altman-Z 5.33
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

LINX has a Current Ratio of 2.14. This indicates that LINX is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 2.14
Quick Ratio N/A

More info and screens

3

3. Growth

3.1 Past

The earnings per share for LINX have decreased strongly by -287.77% in the last year.
LINX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -17.40%.
The Revenue has been decreasing by -4.79% on average over the past years.
EPS 1Y (TTM)-287.77%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q35.45%
Revenue 1Y (TTM)-17.4%
Revenue growth 3Y-4.79%
Revenue growth 5YN/A
Revenue growth Q2Q-10.42%

3.2 Future

Based on estimates for the next years, LINX will show a very strong growth in Earnings Per Share. The EPS will grow by 55.03% on average per year.
The Revenue is expected to grow by 13.01% on average over the next years. This is quite good.
EPS Next Y150.95%
EPS Next 2Y76.71%
EPS Next 3Y59.12%
EPS Next 5Y55.03%
Revenue Next Year12.07%
Revenue Next 2Y13.42%
Revenue Next 3Y12.86%
Revenue Next 5Y13.01%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

LINX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 78.08, LINX can be considered very expensive at the moment.
LINX's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 20.72.
Industry RankSector Rank
PE N/A
Fwd PE 78.08

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 63.22

4.3 Compensation for Growth

LINX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
LINX's earnings are expected to grow with 59.12% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y76.71%
EPS Next 3Y59.12%

More info and screens

1

5. Dividend

5.1 Amount

LINX has a Yearly Dividend Yield of 1.20%.
With a Dividend Yield of 1.20, LINX pays less dividend than the S&P500 average, which is at 2.41.
Industry RankSector Rank
Dividend Yield 1.2%

5.2 History

LINX does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

DPN/A
EPS Next 2Y76.71%
EPS Next 3Y59.12%

More info and screens

Linx S.A. ADR

NYSE:LINX (6/25/2021, 7:04:00 PM)

7.5

-0.2 (-2.6%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.42B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 1.2%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 78.08
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.12%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM -5.11%
PM (TTM) -8.93%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.14
Quick Ratio N/A
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-287.77%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y150.95%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-17.4%
Revenue growth 3Y-4.79%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y